Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Actinium-225

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-secures-a-supply-agreement-with-ionetix-corporation-to-accelerate-ac-225-radiotherapeutics-development-302645520.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Niowave Expands Supply Deal With Astrazeneca For Actinium-225
    Niowave Expands Supply Deal With Astrazeneca For Actinium-225

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/niowave-expands-global-supply-agreement-with-astrazeneca-to-deliver-actinium-225-for-next-generation-cancer-therapies-302646279.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Cellectar Bio Inks Actinium-225 Deal With Ionetix
    Cellectar Bio Inks Actinium-225 Deal With Ionetix

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206203/29076/en/Cellectar-Biosciences-Announces-Strategic-Supply-Agreement-with-Ionetix-for-Actinium-225-and-Astatine-211-to-Advance-Targeted-Alpha-Therapies.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma
    Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alpha-9-oncology-announces-first-patient-dosed-in-phase-1-study-of-a9-3408-for-the-treatment-of-melanoma-302632371.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Actinium Reveals ATNM-400's Strong Efficacy in Breast Cancer
    Actinium Reveals ATNM-400's Strong Efficacy in Breast Cancer

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-atnm-400-data-demonstrating-potent-efficacy-in-triple-negative-breast-cancer-and-ability-to-overcome-endocrine-and-her2-targeted-therapy-resistance-being-presented-at-the-san-antonio-breast-cance-302629128.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    AtomVie Delivers First 225Ac-SSO110 Dose for Ariceum Ph1/2 Trial
    AtomVie Delivers First 225Ac-SSO110 Dose for Ariceum Ph1/2 Trial

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-supplies-the-first-patient-dose-of-225ac-sso110-for-ariceum-therapeutics-phase-12-santana-225-clinical-trial-in-extensive-stage-small-cell-lung-cancer-and-merkel-cell-carcinoma-302612102.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.